Five takeaways from its financial results released May 5:
1. Net sales were $271.2 million. That’s a 4.4 percent increase compared to the same period last year. The increase was credited to month-over-month improvement in U.S. procedural volumes and low double-digit international growth.
2. The company saw a GAAP net loss of $7.5 million, or diluted loss per share of $0.15.
3. NuVasive had a non-GAAP net income of $19 million, which is down 25.2 percent compared to the first quarter last year.
4. NuVasive retired $650 million of convertible debt at maturity and funded the $150 million payment to acquire Simplify Medical.
5. The company has seen positive feedback on the Simplify Medical acquisition, and it plans to launch the Pulse platform later this year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.